- within Government and Public Sector topic(s)
- with Senior Company Executives, HR and Finance and Tax Executives
- in European Union
- with readers working within the Accounting & Consultancy, Banking & Credit and Pharmaceuticals & BioTech industries
In an effort to improve patient outcomes and increase efficiency within Ontario's healthcare system, the provincial government has launched a new initiative: the Health Innovation Pathway (the "HIP"). This program invites vendors to submit proposals for innovative technologies that enhance care and streamline health services. Successful proposals will be tested, validated, and adopted for use within the public health system through public imbursement.
Developed by Ontario Health and the Ministry of Health, the HIP is integrated into the province's broader Life Sciences Strategy, which aims to position Ontario as a global hub for biomanufacturing and life sciences innovation. As part of this strategy, the provincial government has committed C$201 million in funding.
A key focus of the HIP is selecting and adopting more Ontario-made technologies. These include:
- medical devices and procedures;
- digital health tools;
- medical imaging and screening;
- laboratory and genetic testing; and
- models of health care delivery.
As part of the HIP, Ontario is supporting four cutting-edge projects through the Health Technology Accelerator Fund: wound care management, AI-powered screening to prevent vision loss, computer-assisted navigation systems for total hip and knee arthroplasty, and abdominal wall surgical supports.
In light of the burden on Ontario's healthcare system, the launch of the HIP has been met with enthusiasm and optimism, with Ontarians viewing it as an impactful and necessary step toward meaningful innovation and system-wide improvement.
The content of this article does not constitute legal advice and should not be relied on in that way. Specific advice should be sought about your specific circumstances.
